ArticleJournal of Cancer2025

An integrated analysis identified mitochondrial ribosomal protein MRPL3 as a potential prognostic biomarker and therapeutic target in pancreatic cancer.

Wuhan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.